Delivery Order SPE2DR25D2009-SPE2DR26FJ6D3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,516.87 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract. The award was issued on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement through DLA's medical supply chain, with performance to occur at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $30.18K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a completion date of January 21, 2026. This non-set-aside award was made on January 20, 2026, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,601.07 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 29, 2026, with a completion date of January 30, 2026. This non-set-aside contract utilizes firm fixed-price pricing and is executed from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,826.54. This is a firm fixed-price delivery order with an ultimate completion date of July 3, 2025, and represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,928.15 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.06 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60 count) under a firm fixed price contract. The order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...
- The Defense Logistics Agency awarded a $9,629.19 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $1,802.42 to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in tuberculosis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Rifampin 300 mg capsules in quantities of 60 units, with a ceiling value of $6,960.94 and an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order structure and represents a task order under the company's broader pharmaceutical supply agreement with DLA Troop Support Medical. The place...
- The Defense Logistics Agency awarded a delivery order valued at $52,050.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a completion date of January 29, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ6D3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,906.53 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count units). This firm fixed-price, competitively awarded contract was issued on February 3, 2026, with an ultimate completion date of February 4, 2026. The pharmaceutical products will be performed at AmerisourceBergen Drug Corp's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation and represents a routine procurement of a critical antibiotic medication to support federal medical supply needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, which is valued up to $999.99 million through December 31, 2031. The IDC serves as a comprehensive vehicle for supplying pharmaceutical products and medical commodities globally to support military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal medical institutions. AmerisourceBergen's role as a prime pharmaceutical vendor demonstrates its critical position within the federal medical supply chain, enabling efficient fulfillment of essential medications required across multiple government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/2/26 |